期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 4, 期 12, 页码 1203-1207出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml400324c
关键词
Inhibitor; CYP11B2; aldosterone synthase; aldosterone; hypertension; enzyme; CYP11B1; Cushing's syndrome; cortisol
Aldosterone is a key signaling component of the renin-angiotensin-aldosterone system and as such has been shown to contribute to cardiovascular pathology such as hypertension and heart failure. Aldosterone synthase (CYP11B2) is responsible for the final three steps of aldosterone synthesis and thus is a viable therapeutic target A series of imidazole derived inhibitors, including clinical candidate 7n, have been identified through design and structure-activity relationship studies both in vitro and in vivo. Compound 7n was also found to be a potent inhibitor of 11 beta-hydroxylase (CYP11B1), which is responsible for cortisol production. Inhibition of CYP11B1 is being evaluated in the clinic for potential treatment of hypercortisol diseases such as Cushing's syndrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据